Curtis A. Hanson

Also affiliated with Mayo Clinic, WinnMed, Mayo Clinic in Arizona

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 17 papers. Top paper: “Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial”.

Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

Blood(2022)10.1182/blood.2021014960

N/A

5.5DataRank · unranked

240 citations

Victoria Wang, Curtis A. Hanson, Elisabeth Paietta, Susan O’Brien, Jacqueline C. Barrientos +17 more

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans

Leukemia(2021)10.1038/s41375-021-01344-9

N/A

0.726DataRank · unranked

22 citations

J. Brice Weinberg, Sameer A. Parikh, Esteban Braggio, Sara J. Achenbach, Dennis P. Robinson +17 more

Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL)

Blood(2013)10.1182/blood-2012-12-470005

N/A

0.661DataRank · unranked

81 citations

Alan G. Ramsay, Clive S. Zent, Jose F. Leis, Han W. Tun, Timothy G. Call +7 more

Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases

American Journal of Hematology(2021)10.1002/ajh.26186

N/A

0.631DataRank · unranked

66 citations

Paola Guglielmelli, Natasha Szuber, Kebede H. Begna, Mrinal M. Patnaik, Mark R. Litzow +11 more

Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm

Haematologica(2022)10.3324/haematol.2022.282019

N/A

0.449DataRank · unranked

19 citations

Rimal Ilyas, Kristen McCullough, Kebede H. Begna, Aref Al-Kali, Mrinal M. Patnaik +13 more

The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis

Blood Cancer Journal(2022)10.1038/s41408-022-00754-x

N/A

0.345DataRank · unranked

9 citations

Sara J. Achenbach, Kari G. Rabe, Aaron D. Norman, Nicholas Boddicker, Janet E. Olson +9 more

Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis

Blood Advances(2024)10.1182/bloodadvances.2023012242

N/A

0.330DataRank · unranked

8 citations

Nicholas Boddicker, Daniel R. O’Brien, Cristine Allmer, Kari G. Rabe, Aaron D. Norman +23 more

Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)

Blood Cancer Journal(2024)10.1038/s41408-024-01175-8

N/A

0.312DataRank · unranked

7 citations

Rosalie Griffin, Sameer A. Parikh, Giulio Genovese, Dennis P. Robinson, Aaron D. Norman +14 more

Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912

Blood Advances(2025)10.1182/bloodadvances.2024013474

N/A

0.292DataRank · unranked

6 citations

Victoria Wang, Curtis A. Hanson, Elisabeth Paietta, Susan O’Brien, Jacqueline C. Barrientos +16 more

Relationship among three common hematological premalignant conditions

Leukemia(2023)10.1038/s41375-023-01914-z

N/A

0.241DataRank · unranked

4 citations

Sameer A. Parikh, Aaron D. Norman, Kari G. Rabe, Rosalie Griffin, Timothy G. Call +14 more

Risk of incident melanoma among individuals with low-count monoclonal B-cell lymphocytosis (MBL).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7577

N/A

0.104DataRank · unranked

1 citations

Ahmed Ansari, Sameer A. Parikh, Sara J. Achenbach, Kari G. Rabe, Aaron D. Norman +10 more

CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)

Blood Cancer Journal(2025)10.1038/s41408-025-01385-8

N/A

0DataRank · unranked

1 citations

Tait D. Shanafelt, Sameer A. Parikh, Kari G. Rabe, R. L. Griffin, Aaron D. Norman +16 more

Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis

Leukemia(2022)10.1038/s41375-022-01514-3

N/A

0DataRank · unranked

5 citations

Sara J. Achenbach, Sameer A. Parikh, Geffen Kleinstern, Esteban Braggio, Aaron D. Norman +11 more

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families

Blood(2020)10.1182/blood.2020006322

N/A

0DataRank · unranked

36 citations

Mark C. Lanasa, Gerald E. Marti, Sara J. Achenbach, Nicola J. Camp, Fatima Abbasi +23 more

Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib

Blood(2021)10.1182/blood.2020010146

N/A

0DataRank · unranked

35 citations

Curtis A. Hanson, Renee C. Tschumper, Connie Lesnick, Esteban Braggio, Elisabeth Paietta +17 more

Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis

Journal of Clinical Oncology(2024)10.1200/jco.24.00332

N/A

0DataRank · unranked

4 citations

Ahmed Ansari, Sameer A. Parikh, Sara J. Achenbach, Kari G. Rabe, Aaron D. Norman +10 more

Examining two hematologic precursors and their impact on incident lymphoid malignancies.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.7011

N/A

0DataRank · unranked

0 citations

Rosalie Griffin, E.G. Franke, Sara J. Achenbach, Kari G. Rabe, Janet E. Olson +14 more